Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 ...

CEO Thomas Equels discusses recent clinical progress, upcoming milestones and the Company's commitment to advancing Ampligen® for patients with pancreatic cancer ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

C1 Monoclonal Antibody Progress for RSV and Malaria Following Full $3.1 Million Gates Foundation Grant FundingJUPITER, Fla., July 07, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ...

Alpha Tau Medical (DRTS) pioneers alpha emitter-based targeted radiation therapy, aiming for highly localized tumor ...

MeiraGTx to receive up to $375 million in non-dilutive cash and up to $25 million in equity investmentFollowing regulatory approval, Oberland Capital to receive low single-digit capped royalties on th ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has completed enrollment in the pivotal cohort (Cohort 1) of the global Phase 3 REVEAL study evaluating obudanersen (ION582), an ...

The University of Melbourne is seeking a new senior lecturer in mathematical physics — but only women (cis or trans) need ...

Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 ...

L3Harris has secured a potential $499.6 million follow-on contract to sustain the MDA's Flight Test Airborne Sensors program ...

District 8 Political party: Democrat Campaign website: Current occupation: State Representative Age: 65 Don't miss out on what's happening! Stay in touch ...

New York City will roll out more than 1,000 new 3-K seats this fall, with a focus on neighborhoods where "demand has outstripped supply," Mayor Zohran Mamdani said Tuesday. The new seats will be ...